Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Nektar Therapeutics”

423 pharma patents match "Nektar Therapeutics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 423
Index total 30,257
Page 2 / 18

Quick answer

This filtered view shows 423 pharmaceutical patents matching "Nektar Therapeutics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

423 results for “Nektar Therapeutics” · 30,257 patents in full index Clear search

  1. US 11220575

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted
  2. US 11141465

    Method of making a water-soluble polymer-factor VIII moiety conjugate

    Nektar Therapeutics · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  3. US 11129794

    Chemically modified small molecules

    Nektar Therapeutics · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  4. US 11111214

    Kappa opioid agonists and uses thereof

    Nektar Therapeutics · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  5. US 11111335

    Method of preparing carboxylic acid functionalized polymers

    Nektar Therapeutics · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  6. US 11091525

    Method of refolding an interleukin-2 (IL-2) protein

    Nektar Therapeutics · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  7. US 11033631

    Methods of treating CYP2D6 alternative metabolizers

    Nektar Therapeutics · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  8. US 11007270

    Polymer-semaxanib moiety conjugates

    Nektar Therapeutics · Granted May 18, 2021 · Expires May 13, 2041

    granted
  9. US 10960079

    Conjugates of an IL-2 moiety and a polymer

    Nektar Therapeutics · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  10. US 10945972

    Particulate materials

    Nektar Therapeutics · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  11. US 10941248

    Methods for preparing functionalized polymers from polymer alcohols

    Nektar Therapeutics · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  12. US 10894087

    Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds

    Nektar Therapeutics · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted
  13. US 10881738

    Oligomer-beta blocker conjugates

    Nektar Therapeutics · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  14. US 10869933

    Oligomer-phenothiazine conjugates

    Nektar Therapeutics · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  15. US 10865186

    Opioid agonists and uses thereof

    Nektar Therapeutics · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted
  16. US 10844076

    Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

    Nektar Therapeutics · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  17. US 10806794

    Protease inhibitors having enhanced features

    Nektar Therapeutics · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  18. US 10798955

    Compositions of particulate coformulation

    Nektar Therapeutics · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  19. US 10786552

    Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

    Nektar Therapeutics · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  20. US 10774181

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  21. US 10766864

    Morphinan derivatives for the treatment of neuropathic pain

    Nektar Therapeutics · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  22. US 10759906

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  23. US 10736969

    Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

    Nektar Therapeutics · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  24. US 10695435

    Composition comprising a polymeric reagent

    Nektar Therapeutics · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted